Shernan Holtan: Latest Publication on PTCy
Shernan Holtan, Chief of Blood and Marrow Transplantation, Professor of Medicine at Roswell Park Comprehensive Cancer Center, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Cureus, adding::
“New to PTCy?
Read and bookmark our latest publication.
With most PTCy platforms, there is no immunosuppression given until PTCy starts on day plus 3.
That gives 3 days for those mature, potentially alloreactive T cells that went along for a ride with the stem cells in the infusion bag to throw a party.
Between infusion and day 3 (and sometimes later), that T cell party can lead to some pretty unique and even scary inflammatory manifestations.
The good news is that if you recognize the patterns, you can intervene and keep the patient safe.
Read our case report to learn more!”
Title: Early-Onset Hemophagocytic Lymphohistiocytosis and Inflammatory Neurotoxicity Prior to Post-transplant Cyclophosphamide: A Report of Two Cases
Authors: Kashish Shah, Brian C. Betts, Maureen Ross, Alicia Lieberman, Marco L. Davila, Shernan Holtan
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 2, 2026, 14:07Faheema Hasan: A New Second-Line Therapy for Essential Thrombocythemia
-
Sep 2, 2026, 14:05Andrew Kuykendall: FDA Approves Rusfertide for Polycythemia Vera
-
Sep 2, 2026, 13:50Yazhini Selvaraj: Cold Agglutination in Cardiopulmonary Bypass
-
Sep 2, 2026, 09:52Rick Matthews: Expanding Mechanical Thrombectomy to Coronary Arteries
-
Sep 2, 2026, 09:49Yara Dixon: Barriers and Facilitators to Blood Donation Across Diverse Populations
-
Sep 2, 2026, 09:29Ana Sachetto: Liver Injury and Tissue Factor-Driven Coagulation
-
Sep 2, 2026, 09:28Kavya Keerthana: A Potentially Important Advance in Polycythemia Vera
-
Sep 2, 2026, 09:26Mohammad Zuryan: Pre-Marital Genetic Screening for Thalassemia Prevention
-
Sep 2, 2026, 09:23Mohammed Salman: 9 Key Changes in the Fifth Universal Definition of Myocardial Infarction